New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures

Erin Kutz4/9/12Follow @xconomy

(Page 17 of 24)

	NEXT IMAGE>>
	New England’s Emerging Biotech Stars — Dicerna CEO Doug Fambrough
	Photo by Keith Spiro Photography courtesy of Kendall Press

Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 previous page

Share or Leave a Comment

Reprints E-mail +1 Twitter LinkedIn Facebook Hacker News Comment

Related Posts

Comments are closed.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!